A Prospective, Single-Center, Double-Blind, Placebo-Controlled Trial of BOL-DP-o-04 in Patients With Low Back Pain and Sciatica
Latest Information Update: 13 Dec 2022
At a glance
- Drugs BOL DP o 04 (Primary)
- Indications Back pain; Sciatica
- Focus Therapeutic Use
- Sponsors BOL Pharma
Most Recent Events
- 07 Dec 2022 Status changed from active, no longer recruiting to completed.
- 29 Aug 2021 Planned End Date changed from 30 Nov 2020 to 31 Dec 2021.
- 29 Aug 2021 Planned primary completion date changed from 15 Nov 2020 to 31 Dec 2021.